Two Centre members have been successful in winning government funding to develop AI technologies to improve diagnosis and speed up life-saving cancer treatment.
Recent work at the University of Cambridge on kidney cancer screening, led by Dr Juliet Usher-Smith and Professor Grant Stewart and funded by Kidney Cancer UK, reveals positive public attitudes towards a potential screening programme.
Congratulations to Prof Rebecca Fitzgerald and Dr John Marioni who have been elected as EMBO members in recognition of their outstanding life science research.
British duo Professor Shankar Balasubramanian and Professor David Klenerman have been awarded the Millennium Technology Prize for their development of revolutionary DNA sequencing techniques.
Congratulations to Professor Julie Ahringer, Dr Peter Campbell, Professor David Rowitch and Professor Ben Simons on their election as Fellows of the Royal Society.
A new way to identify tumours that could be sensitive to particular immunotherapies has been developed using data from thousands of NHS cancer patient samples sequenced through the 100,000 Genomes Project.